Abstract
A 31-year-old homosexual man with AIDS, bilateral cytomegalovirus (CMV) retinitis and optic neuritis in one eye, was treated with DHPG. The drug is an acyclic nucleoside analogue of guanosine with antiviral activity. The visual acuity at the start of treatment was R.E.: no light perception and L.E.: 1.25. There was bilateral regression of retinal exudates on DHPG 5 mg/kg twice a day during 2 weeks. The visual result however was poor because of the optic nerve involvement, which did not improve during DHPG treatment. Four weeks later there was a recurrence of retinitis with the development of exudative retinal detachment in the eye with optic neuritis, despite maintenance therapy of 5 mg/kg once a day Monday through Friday. The dose was increased to 5 mg/kg twice a day, but after 1 week treatment had to be discontinued because of neutropenia. Eight days later treatment was restarted with DHPG 5 mg/kg in a single daily dose during 17 days, which led to remission of retinitis but retinal reattachment did not occur. Thereafter maintenance therapy was continued. Visual acuity remained unchanged. DHPG appears to be effective in treating cytomegalovirus retinitis but long-term suppressive therapy would be necessary to prevent recurrence of the retinitis.
Similar content being viewed by others
References
Palestine AG, Stevens G, Lane HC, Masur H, Fujikawa LS, Nussenblatt RB, Rook AH, Manischewitz J, Baird B, Megill M, Quinnan G, Gelmann E, Fauci AS. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol 1986; 101: 95–101.
Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology 1985; 92: 472–484.
Rasmussen L, Chen PT, Mullenax JG, Merigan TC. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons. Antimicrob Agents Chemother 1984; 26: 441–445.
Robinson MR, Streeten BW, Hampton GR, Siebold EC, Taylor-Findlay BS. Treatment of cytomegalovirus optic neuritis with dihydroxy propoxymethyl guanine. Am J Ophthalmol 1986; 102: 533–534.
Broughton WL, Cupples HP, Parver LM. Bilateral retinal detachment following cytomegalovirus retinitis. Arch Ophthalmol 1978; 96: 618–619.
Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med 1980; 93: 664–670.
Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome, ocular manifestations. Ophthalmology 1983; 90: 859–873.
Palestine AG, Rodrigues MM, Macher AM, Chan CC, Lane HC, Fauci AS, Masur H, Longo D, Reichert CM, Steis R, Rook AH, Nussenblatt RB. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984; 91: 1092–1099.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hooymans, J.M.M., Sprenger, H.G. & Weits, J. Treatment of cytomegalovirus retinitis with DHPG in a patient with AIDS. Doc Ophthalmol 67, 5–12 (1987). https://doi.org/10.1007/BF00142691
Issue Date:
DOI: https://doi.org/10.1007/BF00142691